A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

NCT01065454 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Pulmonary
Ventricular Dysfunction, Left

Interventions

DRUG: Riociguat (Adempas, BAY63-2521)
DRUG: Riociguat (Adempas, BAY63-2521)
DRUG: Riociguat (Adempas, BAY63-2521)
DRUG: Placebo

Sponsor

Bayer